卓勝微(300782.SZ)一季度預盈4.81億-4.96億元 同比增長216.85%-226.73%
格隆匯 4 月 11日丨卓勝微(300782.SZ)公佈,預計2021年第一季度歸屬於上市公司股東的淨利潤4.81億元-4.96億元,同比增長216.85%-226.73%。其主要原因一方面系5G通信技術的發展帶動了射頻前端市場需求的快速增長,公司抓住5G和國產替代發展機遇,不斷豐富和優化產品結構,在保持射頻分立器件競爭優勢的同時,持續推進射頻模組產品的市場化進程。另一方面,去年同期新冠疫情對客户需求造成了一定的負面影響。
報吿期內,非經常性損益對歸屬於公司股東的淨利潤影響額約-1444.49萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.